DHS: PUBLIC HEALTH DIVISION

Selected Reportable Communicable Disease Summary 2007 State of Oregon

Independent. Healthy. Safe. Oregon Public Health Division Office of Disease Prevention and Epidemiology Acute and Communicable Disease Prevention

2007 State of Oregon Selected Reportable Communicable Disease Summary

800 N.E. Oregon Street, Suite 772 Portland OR 97232 Phone: 971-673-1111

E-mail: [email protected] Web site: http://oregon.gov/DHS/ph/acd

Compiled and prepared by June Bancroft, M.P.H., epidemiologist Leslie Byster, administrative specialist

This document can be furnished in alternate formats for individuals with disabilities. Available formats are large print, Braille, audio tape, electronic, oral presentation and computer disk (in ASCII format). Call 971-673-1111.

December 2008

2007 Oregon Communicable Disease Summary About surveillance data

Oregon law specifies diseases of public health importance that must be reported to local public health authorities by diagnostic laboratories and health care professionals.1 In general, local public health officials investigate reports of a communicable disease in order to characterize the illness and collect demographic information about the case, to identify possible sources of the infection, and to take steps to prevent further transmission. Basic information about each case is forwarded to the Oregon Public Health Division. In some cases (e.g., infection), laboratories are required to forward bacterial isolates to the Oregon State Public Health Laboratory for subtyping. Together, these epidemiologic and laboratory data constitute our communicable disease surveillance system; data from 2007 and trends from recent years are summarized in this report.

But caveat lector! Disease surveillance data have many limitations.

First, for most diseases, reported cases represent but a fraction of the true number. The most important reason for this is that many patients — especially those with mild disease — do not present themselves for medical care. Even if they do, the health care professional may not order a test to identify the causative . The reader may be scandalized to learn that not every reportable disease gets reported as the law requires. Cases are “lost” to surveillance along i each step of the path from patient to physician to laboratory to public health department; in the case of salmonellosis, for example, reported cases are estimated to account for only about 3% of the true number.2

Second, cases that do get reported are a skewed sample of the total. More severe illnesses (e.g., meningococcal disease) are more likely to be reported than milder illnesses. Infection with virus is more likely to cause symptoms (and those symptoms are more likely to be severe) in adults than in children. Testing is not random; clinicians are more likely to test stool from children with bloody for E. coli O157 than they are to test stool from adults with bloody diarrhea. Health care professionals may be more inclined to report contagious diseases such as tuberculosis — where the public health importance of doing so is obvious — than they are to report non-contagious diseases such as Lyme disease. Outbreaks of disease or media coverage about a particular disease can greatly increase testing and reporting rates.

2007 Oregon Communicable Disease Summary In 2007 population estimates for rate calculations were obtained from the Center for Population Research at Portland State University (www.pdx.edu/prc). Using rates instead of case counts allows for comparisons between populations of different sizes — e.g., versus Oregon. Rates are usually reported as cases per 100,000 persons per year. However, if the population in which the rate is calculated is very small (e.g., in “frontier” counties in Oregon), a case or two might mean the difference between a rate of zero and a very high rate. To compensate for this, some of our maps showing rates by county give an average over multiple years of data or report case counts per county. Even with this aggregation, for some conditions, the number of cases remains small. In addition, the rates presented are not adjusted for age due to the small number of cases in each age group.

Also keep in mind that cases are assigned to the county of residence at the time of the report — not to the county in which the case received medical care.

Even with these limitations, surveillance data are valuable in a variety of ways. They help identify demographic groups at higher risk of illness. They allow analysis of disease trends and identify outbreaks of disease.

With this in mind, we present the 2007 communicable disease summary. This year we present 20 years of data whenever possible. For most of the diseases, we include ii the following: figures showing case counts by year for the past 20 years; aggregate case counts by month to demonstrate any seasonal trends; incidence by age and sex; incidence in Oregon compared to national incidence over the past 20 years; and incidence by county. Where appropriate, additional data on subtypes or risk factors are included. At the end of the booklet you will find a brief tally of disease outbreaks reported in the past year, a summary table of statewide case counts over the past 20 years and disease totals by county.

We hope that, with all their limitations, you will find these data useful. If you have additional questions, please call our epidemiology staff at 971-673-1111 or e-mail [email protected].

Paul R. Cieslak, M.D. Manager, Acute and Communicable Disease Prevention

1 Oregon Administrative Rules, chapter 333, division 18. Available at http://oregon.gov/DHS/ph/acd/oars/div18.shtml#018-0015. 2 Chalker RB, Blaser MJ. A review of human salmonellosis: III. Magnitude of Salmonella infection in the 2007 United Oregon States. Communicable Rev Infect Disease Dis 1988; Summary 10:111-24. Table of contents

About surveillance data...... i List of contributors...... iv AIDS and HIV infection...... 1 Campylobacteriosis...... 4 Chlamydiosis...... 8 ...... 11 Escherichia coli O157 infection...... 15 ...... 18 Gonorrhea...... 22 Haemophilus influenzae ...... 25 Hepatitis A...... 29 Hepatitis B...... 33 Chronic hepatitis B...... 36 Hepatitis C...... 39 Acute hepatitis C...... 40 Chronic hepatitis C...... 42 Legionellosis...... 44 Listeriosis...... 47 Lyme disease...... 50 Malaria...... 54 iii ...... 57 Meningococcal disease...... 60 Mumps...... 64 Pertussis...... 65 Rabies...... 68 Salmonellosis...... 72 Shigellosis...... 76 Early syphilis...... 80 Tuberculosis...... 83 Tularemia ...... 87 Vibriosis...... 89 West Nile virus...... 91 Yersiniosis...... 94 Disease outbreaks...... 96 Public health reporting for clinicians...... 97 Public health reporting for laboratories...... 99 Selected cases of notifiable diseases by year...... 101 Selected cases of notifiable diseases by county of residence...... 102

2007 Oregon Communicable Disease Summary Office of Disease Prevention and Epidemiology List of contributors

June Bancroft, M.P.H. Leslie Byster Paul Cieslak, M.D. Emilio DeBess, D.V.M., M.P.V.M. Doug Harger Shannon Hiratzka, M.P.H. Bill Keene, Ph.D., M.P.H. Juventila Liko, M.D., M.P.H. Tasha Poissant, M.P.H. Barbara Progulske, D.V.M., M.P.H., D.A.C.V.P.M. Sean Schafer, M.D. Beletshachew Shiferaw, M.D., M.P.H.

2007 Oregon Communicable Disease Summary AIDS and HIV infection

Human immunodeficiency virus (HIV) is spread by having sex, sharing injection drug equipment, or receiving a transfusion or transplant from an infected person. It can be spread from mother to fetus, to infant at the time of delivery, or by breastfeeding. Rarely, HIV spreads by inadvertent exposure to bodily fluids of an infected person such as a contaminated needle stick in a healthcare worker. The acquired immunodeficiency syndrome (AIDS) represents the late stage of HIV infection with immune system impairment, marked by low CD4-positive lymphocyte counts and opportunistic or atypical infections. There is no cure for HIV infection, but treatment can prolong life and reduce transmission.

HIV infection can be avoided by abstaining from sex outside of a monogamous relationship with an uninfected partner and by not injecting recreational drugs. Using a condom during intercourse and not sharing injection drug equipment also reduce risk of acquiring HIV. A pregnant woman who is infected with HIV can minimize transmission of infection to her fetus by taking during pregnancy and refraining from breastfeeding. Caesarean section may also prevent transmission when the mother’s infection is not well controlled. 1 As of July 2008, 8,252 cases of HIV infection (including cases that had, and cases that had not yet progressed to AIDS) had been diagnosed among Oregon residents between 1981 and 2007 and reported to the Oregon HIV/STD/TB Program; 3,330 of these case-patients had died, leaving 4,922 living with HIV infection. Approximately 60% of these infections had progressed to AIDS by the end of 2007. In addition, approximately 1,250 people are estimated to be infected, but not yet diagnosed; almost 2,000 people with HIV infection who resided in another state at the time of their diagnosis had moved to Oregon by the end of 2007.

Men accounted for 88% of prevalent cases. Whites accounted for 80%, blacks and/or African Americans, 7%, and Hispanics, 10%. Among men, annual incidence of new HIV diagnoses was 11.2 cases per 100,000 whites, 21.3 cases per 100,000 blacks and/or African Americans and 18.6 per 100,000 among Hispanics. Among females, these rates were 1.3, 2.6 and 3.3 respectively.

2007 Oregon Communicable Disease Summary Seventy percent of infected men in Oregon acquired their infection by sex with other men, while 9% of men with HIV acknowledged both sex with other men and previous injection drug use, obscuring their most likely transmission mode. Injection drug use was the most likely transmission mode for 9% and heterosexual transmission the most likely mode for 8%. Among women with HIV infection, heterosexual transmission was believed to be the most likely mode for 69% and injection drug use for 25%.

Incidence of HIV infection by sex and year of diagnosis: Oregon, 1981–2007

40 Male Female 35

30

25

20

15

Cases/100,000 10

2 5

0

1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 Year

2007 Oregon Communicable Disease Summary New cases of HIV infection by age and sex at diagnosis: Oregon, 2007

45 Males Females 40

35

30

25

Cases 20

15

10

5

0 13–24 25–29 30–34 35–39 40–44 45–49 50+ Age at diagnosis (years)

Persons living with HIV or AIDS by county of residence: Oregon, 1998–2007

Clatsop 3

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–13.0

Harney Malheur Coos Douglas 13.1–42.6

42.7–62.2

Lake 62.3–106.1 Josephine Jackson Klamath

Curry 106.2–397.95

2007 Oregon Communicable Disease Summary Campylobacteriosis

Campylobacteriosis is caused by a Gram-negative bacterium. It is characterized by acute onset of diarrhea, , , and malaise. Campylobacteriosis is the most common bacterial enteric infection reported. It is of worldwide epidemiologic importance due to the fecal-oral route of infection and the extensive reservoir of the organism in both wild and domestic animals.

Children aged 0–4 years have the highest rates of illness. Infections occur year-round in Oregon, with peak incidence in the summer months. Campylobacteriosis is not nationally reportable. Rates are highest in Malheur, Harney, Wheeler and Tillamook counties.

Most illnesses are sporadic, but outbreaks may be associated with undercooked (often chicken), unpasteurized milk, direct contact with animals or non- chlorinated water. Since 1998, seven outbreaks of campylobacteriosis have been investigated: two foodborne, two waterborne, two from animal contact, and one of unknown etiology. Proper handling and water treatment, along with good hygienic practices (hand washing!) are the keys to prevention.

Though not statistically significant, the 2007 rate of 19.5 per 100,000 was 4 noticeably higher than the 2006 rate of 17.7.

2007 Oregon Communicable Disease Summary Campylobacteriosis by year: Oregon, 1988–2007

1200

1000

800

600 Cases

400

200

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Campylobacteriosis by report month: Oregon, 2007

90 2007 Median 2000—2006 5 80

70

60

50 Cases 40

30

20

10

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of campylobacteriosis by age and sex: Oregon, 2007

45 Male Female 40

35

30

25

20

Cases/100,000 15

10

5

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of campylobacteriosis: Oregon vs. nationwide, 1988–2007

40 Oregon 6 not a nationally reportable disease

30

20 Cases/100,000

10

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of campylobacteriosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 8.8–11.9

Harney Malheur Coos Douglas 12.0–16.8

16.9–21.9

22.0–27.1 Lake Josephine Jackson Klamath

Curry 27.2–35.3

7

2007 Oregon Communicable Disease Summary Chlamydiosis

Chlamydia trachomatis is Oregon’s most commonly reported infection. In 2007, there were 9,867 cases reported, an increase of 289 cases (3%) compared to cases reported in 2006. The highest rates of infection occur among women in the 15–24 year age group. As with gonorrhea and syphilis, chlamydial infections are transmitted by vaginal, rectal and oral sexual contact. Chlamydiosis may be prevented by abstaining from sexual contact or only having sex with one uninfected sex partner. Those who are sexually active outside of a mutually monogamous relationship can lower their risks of infection by using a condom when engaging in sexual activity.

Chlamydial infections are likely to be silent, with neither men nor women having symptoms. However, reproductive health complications, especially among women, may lead to infertility and an increased risk of tubal pregnancy.

Chlamydiosis by year: Oregon, 1988–2007

12000

10000

8 8000

6000 Cases

4000

2000

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of chlamydiosis by age and sex: Oregon, 2007

1800 Male Female 1600 Case count by selected age group 1400 Age group Male Female 10–14 3 37 1200 15–19 449 2134 20–24 1125 2765 1000 25–29 658 1172 800 Cases/100,000 600

400

200

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of chlamydiosis Oregon vs. nationwide, 1995–2007 9 400 Oregon U.S.

350

300

250

200

Cases/100,000 150

100

50

0

1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of chlamydiosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 31.0–63.0

Harney Malheur Coos Douglas 63.1–107.6

107.7–156.0

Lake 156.1–185.6 Josephine Jackson Klamath

Curry 185.7–366.0

10

2007 Oregon Communicable Disease Summary Cryptosporidiosis

Cryptosporidiosis in humans results from infection with protozoal parasites in the genus Cryptosporidium—most commonly C. hominis or C. parvum. Symptomatic infections are characterized by watery diarrhea and abdominal cramps. Symptoms typically resolve in one to four weeks in immunocompetent persons. Infections can be difficult to control among the immunocompromised. Studies suggest that the prevalence of cryptosporidiosis among young children, particular those in large child care facilities, is surprisingly high. Many of these infections are asymptomatic.

Both nationally and in Oregon the rate of infection with Cryptosporidium has been steadily increasing since 2005. It is not clear whether this is due to increased awareness and testing or the emergence of strains more resistant to routine chlorination practices. In 2007, Oregon had a record 163 cases. Recently the Oregon investigative guidelines were changed to reflect the increasing numbers of cases; previously, investigations were required only for abnormally high case counts. All cases will now be routinely investigated to identify the source of infection.

Given the number of asymptomatic and undiagnosed infections, surveillance data can be difficult to interpret. However, these data have been used to identify 11 a number of outbreaks over the years, most commonly associated with child care or water (both drinking and recreational). In 2007, a large outbreak (44 cases) was identified among campers at a private youth camp.

2007 Oregon Communicable Disease Summary Cryptosporidiosis by year: Oregon, 1988–2007 180

160

140

120

100

Cases 80

60

40

20

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

Year

Cryptosporidiosis by onset month: Oregon, 2007

60 2007 Median 2002—2006 12

50

40

30 Cases

20

10

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of cryptosporidiosis by age and sex: Oregon, 2007

12 Male Female

10

8

6

Cases/100,000 4

2

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of cryptosporidiosis: Oregon vs. nationwide, 1988–2007 6 Oregon U.S. Not nationally reportable until 1995 13 5

4

3 Cases/100,000 2

1

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of cryptosporidiosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0

Harney Malheur Coos Douglas 0.1–0.8

0.9–1.9

2.0–2.7 Lake Josephine Jackson Klamath

Curry 2.8–4.8

14

2007 Oregon Communicable Disease Summary Escherichia coli O157 infection

E. coli O157 (O157) has become one of the most feared common causes of infectious diarrhea. Oregon has been the setting for many O157 outbreaks, and investigations of those outbreaks combined with the analysis of other surveillance information have contributed greatly to our understanding of this pathogen. Spread by the fecal-oral route, O157 has a number of animal reservoirs, the most important of which are ruminants, including cattle, goats, sheep, deer and elk. Transmission often occurs from consumption of contaminated food or water, as well as direct person-to-person spread.

After a spike in 2005 of 149 cases, the yearly total fell back to a more typical 79 reports for 2007 — a phenomenon known as “regression to the mean.” Nationwide, however, reported case counts drifted upwards for the third year in a row.

We identified four O157 outbreaks in 2007. These included a small cluster at a Portland restaurant — specific source uncertain; another small cluster lingering from 2006 associated with visiting a county fairgrounds; another outbreak traced to a regional hamburger distributor; and a two-person blip among persons with a history of travel to Kauai. Summer sees more outbreaks of E. coli than other seasons. 15

E. coli O157 infection by year: Oregon, 1988–2007 300

250

200

150 Cases

100

50

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary E. coli O157 infection by onset month: Oregon, 2007 30 2007 Median 2002—2006

25

20

15 Cases

10

5

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

16 Incidence of E. coli O157 infection by age and sex: Oregon, 2007 7 Male Female

6

5

4

3 Cases/100,000

2

1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age 2007 Oregon Communicable Disease Summary Incidence of E. coli O157 infection: Oregon vs. nationwide, 1988–2007 10 Oregon U.S. 9 Not nationally reportable until 1994 8

7

6

5

4 Cases/100,000 3

2

1

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

Incidence of E. coli O157 infection by county of residence: Oregon, 1998–2007 17

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–1.2

Harney Malheur Coos Douglas 1.3–3.0

3.1–4.5

Lake 4.6–5.6 Josephine Jackson Klamath

Curry 5.7–8.6

2007 Oregon Communicable Disease Summary Giardiasis

Giardia intestinalis, the flagellated protozoan originally namedG. lamblia, is the most commonly identified parasitic pathogen in the United States. Children in day care and their close contacts are at greatest risk, as are backpackers and campers (by drinking unfiltered, untreated water), persons drinking from shallow wells, travelers to disease-endemic areas, and men who have sex with men. Giardia can be excreted in the stool intermittently for weeks or months, resulting in a protracted period of communicability. Transmission occurs when as few as 10 cysts are ingested through person-to-person or animal-to-person contact, or by ingestion of fecally contaminated water or food.

The majority of Giardia infections occur without symptoms. When symptomatic, patients report chronic diarrhea, steatorrhea, abdominal cramps, bloating, frequent loose and pale greasy stools, fatigue, and weight loss.

In 2007, the reported incidence of giardiasis in Oregon remained nearly twice that of the rest of the United States, with 12.4 cases per 100,000 population. All 2007 cases were reported as sporadic or household-associated; no outbreaks were reported. Children less than 5 years of age continue to have the highest 18 incidence, with 34 cases/100,000. Rates of infection tend to be higher in the summer months with transmission related to outdoor activities in or near untreated water.

Prevention depends upon good personal hygiene (hand washing!) and avoiding consumption of fecally contaminated water. Travel warnings on water quality should be heeded.

2007 Oregon Communicable Disease Summary Giardiasis by year: Oregon, 1988–2007

1600

1400

1200

1000

800 Cases

600

400

200

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Giardiasis by onset month: Oregon, 2007

70 2007 Median 2002–2006 19 60

50

40 Cases 30

20

10

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec

Month

2007 Oregon Communicable Disease Summary Incidence of giardiasis by age and sex: Oregon, 2007

45 Male Female 40

35

30

25

20 Cases/100,000 15

10

5

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of giardiasis: Oregon vs. nationwide, 1988–2007 20 50 Oregon U.S. Not nationally reportable until 2002 40

30

Cases/100,000 20

10

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of giardiasis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–7.1

Harney Malheur Coos Douglas 7.2–12.1

12.2–15.5

15.6–19.2 Lake Josephine Jackson Klamath

Curry 19.3–33.1

21

2007 Oregon Communicable Disease Summary Gonorrhea

Gonorrhea, caused by the Gram-negative bacterium Neisseria gonorrhoeae, is easily transmitted from person to person through vaginal, rectal and oral sexual contact. Gonorrhea can be prevented by abstaining from sexual contact or only having sex with one uninfected sex partner. Those who are sexually active outside of a mutually monogamous relationship can lower their risks of infection by using a condom when engaging in sexual activity.

If untreated, gonococcal infections cause a variety of health problems for men, women and infants. The major complications of gonorrhea are infertility and tubal pregnancies among women. Recent sex partners of persons infected with gonorrhea should be evaluated and treated for gonorrhea. The 1,238 gonorrhea cases reported in 2007 represent a decrease of 15% from the 1,459 cases reported in 2006.

Gonorrhea by year: Oregon, 1988–2007

3500

3000

2500 22 2000 Cases 1500

1000

500

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of gonorrhea by age and sex: Oregon, 2007

120 Male Female

100 Case count by selected age group Age group Male Female 10–14 0 4 80 15–19 47 148 20–24 159 179

60 25–29 142 108 Cases/100,000 40

20

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of gonorrhea: Oregon vs. nationwide, 1988–2007 23 300 Oregon U.S.

250

200

150

Cases/100,000 100

50

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of gonorrhea by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–3.0

Harney Malheur Coos Douglas 3.1–8.1

8.2–16.0

16.1–29.8 Lake Josephine Jackson Klamath

Curry 29.9–97.1

24

2007 Oregon Communicable Disease Summary Haemophilus influenzae

Until the advent of an effective vaccine against serotype b (Hib) organisms, Haemophilus influenzae (H. influenzae) was the leading cause of bacterial meningitis in children under 5 years of age in Oregon and elsewhere. Today it is well down the listing, with Streptococcus pneumoniae now in the lead. In Oregon, Hib was cultured from normally sterile body fluids in one adult with a history of recent travel to China. Appropriate use of conjugate vaccine will help ensure that Hib occurrence remains minimal well into the future. All sterile site H. influenzae isolates must be sent to the Oregon State Public Health Laboratory for additional typing.

Concurrent with the decline in Hib infections is an increase in other serotypes. In 2007, 36% of cases were non-typeable, 15% were identified as serotype f, and the remainder were other serotypes. This shift in dominant strains changes the clinical manifestations of illness. From 1998–2007 Oregon clinical manifestations of Oregon cases included primarily (more than 50%), followed by sepsis (35%). Only 9% of cases had meningitis. Concurrent with the changes in clinical manifestations is a shift in age distribution from infants to older persons. As in 2006, the majority of cases in 2007 were among those aged 50 and over. 25 Peak incidence occurs in late winter and early spring. Sixty-six cases, the highest number since 1990, were reported in 2007.

2007 Oregon Communicable Disease Summary H. influenzae by year: Oregon, 1988–2007 160

140

120

100

80 Cases

60

40

20

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

H. influenzae by onset month: Oregon, 2007 10 2007 Median 2002—2006 9 26 8

7

6

5 Cases

4

3

2

1

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of H. influenzae by age and sex: Oregon, 2007 18 Male Female

16

14

12

10

8 Cases/100,000 6

4

2

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

H. influenzae by type and year: Oregon, 1998–2007 45 Non-typeable b f Other type 27 40

35

30

25

Cases 20

15

10

5

0

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of H. influenzae: Oregon vs. nationwide, 1988–2007 6 Oregon U.S.

5 Not nationally reportable until 1995, only Hib consistently reported by states 4

3 Cases/100,000 2

1

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

Incidence of H. influenzae by county of residence: Oregon, 1998–2007 28

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–0.4

Harney Malheur Coos Douglas 0.5–1.0

1.1–1.7

1.8–2.2 Lake Josephine Jackson Klamath

Curry 2.3–3.5

2007 Oregon Communicable Disease Summary Hepatitis A

Hepatitis A is a liver disease caused by the hepatitis A virus, which infects humans via fecal-oral transmission. In Oregon, hepatitis A can occur in situations ranging from isolated cases of disease to statewide outbreaks.

Good personal hygiene and proper sanitation can help prevent hepatitis A. Vaccines are recommended for long-term prevention of hepatitis A in all Oregon children 1 year of age and older, as well as for adults in high-risk groups. Since licensure of the vaccine in 1995–1996, rates of infection have declined nationally and in Oregon, one of the higher incidence states.

In 2007, Oregon adopted the CDC case definition; laboratory positive, asymptomatic infections are no longer reportable. Recent changes in post- exposure prophylaxis include vaccination instead of immune globulin for immune-competent contacts aged 1–40 years. For those over 40 years of age, or with immune-compromising conditions, immune globulin is still recommended.

In 2007, Oregon logged 33 cases of acute hepatitis A. No outbreaks were recorded. Nine (27%) of the 33 cases were acquired by venturing outside of Oregon to countries with high rates of hepatitis A. Such persons placing themselves at elevated risk should receive a dose of hepatitis A vaccine as 29 soon as travel is considered. Completion of the hepatitis A vaccination series (administered according to the licensed schedule) is recommended for long- term protection.

2007 Oregon Communicable Disease Summary Hepatitis A by year: Oregon, 1988–2007 3500

3000

2500

2000 Cases 1500

1000

500

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Hepatitis A by onset month: Oregon, 2007 8 2007 Median 2002—2006 30 7

6

5

4 Cases

3

2

1

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of hepatitis A by age and sex: Oregon, 2007 4 Male Female

3

2 Cases/100,000

1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of hepatitis A: Oregon vs. nationwide, 1988–2007 180 31 Oregon U.S. 160

140

120

100

80

Cases/100,000 60

40

20

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of hepatitis A by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0

Harney Malheur Coos Douglas 0.1–2.0

2.1–3.0

3.1–4.1 Lake Josephine Jackson Klamath

Curry 4.2–6.1

32

2007 Oregon Communicable Disease Summary Hepatitis B

Hepatitis B is a vaccine-preventable viral disease of the liver that occurs when the virus of an infected person passes (through blood, semen, or saliva) into the blood stream of a non-immune person. Percutaneous or permucosal exposures take place when hypodermic needles are shared; when blood splashes into an eye; during sex; by biting; when improperly sterilized injection devices are used for tattooing, body piercing and acupuncture; and when the baby of a mother who is a hepatitis B carrier is being born.

Acute hepatitis B virus infection (diagnosed by the presence in serum of IgM antibody to the hepatitis B core antigen [IgM anti-HBc]) usually, but not always, causes jaundice. Some infections are mild, even asymptomatic, and may go undetected. Hepatitis B has been vaccine-preventable since 1982 and, to promote universal vaccination and hence protection, was added to the recommended childhood immunization schedule in 1992 with the series starting at birth.

Acute hepatitis B continues to decline in Oregon — a decline that started here after the hepatitis B vaccine was licensed in 1982.

Local health departments investigated and reported 61 acute cases in 2007. 33 Sixty-seven percent of the cases were male. The number of cases reporting injection drug use decreased in 2007 (29%) from 2006 (32%).

2007 Oregon Communicable Disease Summary Acute hepatitis B by year: Oregon, 1988–2007

700

600

500

400 Cases 300

200

100

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Incidence of acute hepatitis B by age and sex: Oregon, 2007

6 Male Female 34 5

4

3 Cases/100,000 2

1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

2007 Oregon Communicable Disease Summary Incidence of acute hepatitis B: Oregon vs. nationwide, 1988–2007 30 Oregon U.S.

25

20

15 Cases/100,000 10

5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

Incidence of acute hepatitis B by county of residence: Oregon, 1998–2007 35

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–0.5

Harney Malheur Coos Douglas 0.6–2.1

2.2–3.6

3.7–6.4 Lake Josephine Jackson Klamath

Curry 6.5–9.7

2007 Oregon Communicable Disease Summary Chronic hepatitis B

Persons with chronic hepatitis B are known as “chronic carriers” — a state of infection defined by the persistence of hepatitis B surface antigen (HBsAg) in the blood for more than six months. The likelihood of becoming a chronic carrier is affected by the age at infection. Fewer than 6% of acutely infected adults in the United States become carriers, compared to 25% (with HBeAg- negative moms) to 90% (with HBeAg-positive moms) of children infected in early childhood or during birth. Perinatal infection can be prevented by prompt administration of hepatitis B immune globulin and initiation of the three-dose hepatitis B vaccination series. This perinatal intervention is widely practiced in the United States — all states have federal funding for perinatal hepatitis B prevention programs — but not in other parts of the world, particularly Asia and sub-Saharan Africa, where the prevalence of chronic hepatitis B is higher. In 2007, 56% of chronic carriers were born outside the United States, presumably in hepatitis-B-endemic countries. Chronic carriers are at greater risk of developing life-threatening diseases (e.g., chronic active hepatitis, cirrhosis or liver cancer) decades later. Carriers will sustain transmission of hepatitis B in the United States until vaccine-induced immunity is nearly universal.

36 New recommendations and strategies to prevent new cases include the following: routinely vaccinating all infants at birth; screening all pregnant women for hepatitis B; administering hepatitis B immune globulin (HBIG) in addition to hepatitis B vaccine to infants born to HBsAg-positive mothers; and ensuring that all infants complete the hepatitis B vaccine series.

In 2007, there were 460 newly reported carriers and, as in the past, they were older than acute cases and close to evenly distributed between men and women. Women, however, are diagnosed earlier than men, perhaps due to pre-natal screening. One perinatal hepatitis case was reported in 2007. Chronic carriers are not reportable in many states, so a table comparing Oregon to the rest of the United States is not given.

2007 Oregon Communicable Disease Summary Chronic hepatitis B by year: Oregon, 1988–2007

700

600

500

400 Cases 300

200

100

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Incidence of chronic hepatitis B by age and sex: Oregon, 2007

30 Male Female 37 25

20

15 Cases/100,000 10

5

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

2007 Oregon Communicable Disease Summary Incidence of chronic hepatitis B by county of residence: Oregon 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–1.4

Harney Malheur Coos Douglas 1.5–5.1

5.2–7.8

7.9–13.4 Lake Josephine Jackson Klamath

Curry 13.5–26.9

38

2007 Oregon Communicable Disease Summary Hepatitis C

Infection with hepatitis C virus (HCV) causes acute and chronic hepatitis C disease. HCV is found in the blood of persons who have the disease. The most common of hepatitis C include: jaundice, fatigue, dark urine, abdominal pain, loss of appetite and . However, 80% of persons are asymptomatic. Hepatitis C cases are underreported due to the fact that most persons are asymptomatic and that there are no laboratory tests for acute HCV infection. Hepatitis C can lead to liver damage and sometimes death due to liver breakdown. Nearly 4.1 million people in the United States have been infected with hepatitis C, of whom 3.2 million are chronically infected. Chronic liver disease develops in up to 70% of chronically infected persons. Hepatitis C infection is the leading indication for liver transplant. Currently, 8,000 to 10,000 people die each year in the United States from hepatitis C. There is no vaccine for hepatitis C.

Hepatitis C is spread from one person to another primarily by direct contact with human blood. Most infections are due to illegal injection drug use. The virus can also be transmitted through sexual contact and from infected mothers to their infants at the time of birth. The risk for perinatal HCV transmission is about 4%. If the mother is coinfected with HIV, the risk for perinatal infection increases to about 19%. Since the adoption of routine blood donor screening in 39 1992, transfusion-associated cases now occur less than one per 2 million units of blood transfused.

2007 Oregon Communicable Disease Summary Acute hepatitis C

On average, from 1998–2007, there were 18 acute hepatitis C cases reported per year in Oregon. In 2007, 22 cases were reported. In 50% of the cases, patients were less than 40 years of age, and 59% of all cases were female.

Acute hepatitis C by year: Oregon, 1988–2007* 35

30

25

20 Cases 15

10

5

0

40 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

* Prior to 1993, cases were classified as non-A or non-B hepatitis but not as hepatitis C

2007 Oregon Communicable Disease Summary Incidence of acute hepatitis C by age and sex: Oregon, 2007

3 Male Female

2 Cases/100,000 1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of acute hepatitis C by county of residence: Oregon, 1998–2007 41

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–0.5

Harney Malheur Coos Douglas 0.6–1.3

1.4–2.0

2.1–5.5 Lake Josephine Jackson Klamath

Curry 5.6–17.8

2007 Oregon Communicable Disease Summary Chronic hepatitis C

Chronic hepatitis C was reportable in Oregon as of July 1, 2005. In 2007, 6,323 chronic hepatitis C cases were reported. Preliminary analyses of these data show that infection in males (59%) is higher than females, and in those aged 40–60 years (69%). These numbers are likely an underestimate of the true incidence because most infections are asymptomatic and therefore are not diagnosed or reported to public health.

Chronic hepatitis C by year: Oregon, 1988–2007

7000

6000

5000

Not officially reportable until July 1, 2005. 4000 Cases 3000

2000

42 1000

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of chronic hepatitis C by age and sex: Oregon, 2007

600 Male Female

500

400

300 Cases/100,000 200

100

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of chronic hepatitis C by county of residence: Oregon, 1998–2007 43

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

10.9–43.8

Harney Malheur Coos Douglas 43.9–93.1

93.2–142.1

142.2–216.7 Lake Josephine Jackson Klamath

Curry 216.8–288.0

2007 Oregon Communicable Disease Summary Legionellosis

Legionellosis is usually an acute respiratory tract infection that begins two to 14 days after exposure to Legionella spp. Signs of the disease can include a high fever, chills and cough, in addition to head and muscle aches. Since symptoms are similar to those seen in other forms of pneumonia, the diagnosis is rarely obvious and can be difficult to make. Available diagnostic tests include direct fluorescent antibody staining, culture, polymerase chain reaction on sputum, and urine antigen detection.

“Pontiac Fever,” a milder illness associated with Legionella bacteria, is characterized by fever and without pneumonia. It typically occurs a few hours to two days after exposure.

Legionella bacteria are found naturally in the environment, usually in water, and grow best in warm conditions such as hot tubs, cooling towers, hot water tanks, large plumbing systems, or the air-conditioning systems of large buildings. Person-to-person transmission does not occur.

Risks for infection include older age, smoking, chronic lung disease (like emphysema), renal insufficiency, diabetes and immune deficiency. Death occurs 44 in 10% to 15% of cases: a substantially higher proportion of fatal cases occur during nosocomial outbreaks.

Legionellosis became officially reportable in Oregon in 2001. In 2007, 14 cases of legionellosis were reported among Oregonians. All 14 cases were hospitalized and one died.

2007 Oregon Communicable Disease Summary Legionellosis by year: Oregon, 1988–2007 25

20

15 Cases 10

5

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Incidence of legionellosis: Oregon vs. nationwide, 1998–2007

1.2 Oregon U.S. 45 1.0

0.8

0.6

0.4 Cases/100,000

0.2

0.0

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of legionellosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Rate per 100,000 Deschutes

0.0–0.1

Harney Malheur Coos Douglas 0.2

0.3–0.4

0.5 Lake Josephine Jackson Klamath

Curry 0.5–0.6

46

2007 Oregon Communicable Disease Summary Listeriosis

Listeriosis is a bacterial infection that may present as influenza-like illness with high fever, headache and myalgias; as a gastrointestinal illness; or as an invasive disease with sepsis or meningitis. In pregnant women, listeriosis may cause miscarriages or stillbirths. The case fatality rate of invasive listeriosis is as high as 30% in infants infected prenatally and in non-pregnant adults.

Most cases of listeriosis are sporadic rather than epidemic. However, several large outbreaks have been associated with consumption of contaminated . It is important to track the incidence of this disease to identify such outbreaks, as well as to identify high risk groups. The rate is higher among pregnant women, newborns, the elderly and immunocompromised persons. Cooking food properly is the most important means of prevention. When listerosis is diagnosed, treatment with antibiotics should be instituted promptly.

In 2007, eight cases were reported, a slight decrease from the 13 cases reported in 2006. No outbreak-related cases were reported.

Listeriosis by year: Oregon, 1988–2007

20

18 47

16

14

12

10 Cases 8

6

4

2

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of listeriosis: Oregon vs. nationwide, 1998–2007 2 Oregon U.S.

1 Cases/100,000

0

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Incidence of listeriosis by age and sex: Oregon, 1998–2007

2 48 Male Female

1 Cases/100,000

0

0–4 5–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–85+ Age

2007 Oregon Communicable Disease Summary Incidence of listeriosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0

Harney Malheur Coos Douglas 0.1–0.3

0.4–0.6

0.7–1.0 Lake Josephine Jackson Klamath

Curry 1.1–1.8

49

2007 Oregon Communicable Disease Summary Lyme disease

Lyme disease is a tick-borne zoonotic disease caused by the spirochete Borrelia burgdorferi. The first manifestation in about 60% of patients appears as a red macule or papule (bull’s eye) that expands slowly in an annular manner, sometimes with multiple similar lesions. This distinctive skin lesion is called erythema migrans. The incubation period for Lyme disease ranges from three to 32 days after tick exposure; however, the early stages of the illness may be asymptomatic, and the patient may later develop systemic symptoms and rheumatologic, neurologic or cardiac involvement in varying combinations over a period of months to years.

Currently, increasing recognition of the disease is redefining enzootic areas for B. burgdorferi; Lyme disease cases have been reported in 47 states, and in Ontario and British Columbia, Canada. Elsewhere, related borrelioses have been found in Europe, the former Soviet Union, China and Japan.

In 1997–1998, a tick identification and Borrelia isolation study was conducted by the Centers for Disease Control and Prevention and the Oregon Department of Human Services in Deschutes, Josephine and Jackson counties. No ticks from Deschutes County were identified as carryingBorrelia in this study. The 50 organism was isolated in 3.5% of Ixodes pacificus ticks tested.

During 2007, 27 cases were reported in Oregon, a 20-year high. The median age was 41 years. Eighteen cases (66%) were female. Unlike prior years where case counts were highest in the summer months, cases in 2007 occurred year-round with a peak of five in May.

2007 Oregon Communicable Disease Summary Lyme disease by year: Oregon, 1988–2007

30

25

20

15 Cases

10

5

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Lyme disease by onset month: Oregon, 2007 6 2007 Median 2002—2006 51

5

4

3 Cases

2

1

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of Lyme disease by age and sex: Oregon, 1998–2007 2 Male Female

1 Cases/100,000

0

0–4 5–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–85+ Age

Incidence of Lyme disease: Oregon vs. nationwide, 1988–2007 52 10 Oregon U.S. 9

8

7

6

5

Cases/100,000 4

3

2

1

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of Lyme disease by county of residence*: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–0.2

Harney Malheur Coos Douglas 0.3–0.4

0.5–0.9

1.0–2.0 Lake Josephine Jackson Klamath

Curry 2.1–5.2

*Not necessarily county of acquisition

53

2007 Oregon Communicable Disease Summary Malaria

Worldwide, malaria is one of the most devastating of the communicable diseases, causing perhaps 1 million to 2 million deaths annually, not to mention an enormous burden of disability and medical costs. While transmission has not been documented in Oregon for decades, malaria is reported every year; all cases have resulted from exposures outside the United States. Competent anopheline mosquitoes are resident in Oregon, so limited local transmission remains a theoretical possibility. Oregon rates are similar to the national average. Oregon surveillance data contributes to the national database, which is used to tailor recommendations for prophylaxis and treatment. Plasmodium falciparum (the most severe of the four human parasite species) was the most commonly reported in 2007.

Malaria by year: Oregon, 1988–2007

45

40

35

30

25 54

Cases 20

15

10

5

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of malaria by age and sex: Oregon, 1998–2007 2 Male Female

1 Cases/100,000

0

0–4 5–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–85+ Age

Incidence of malaria: Oregon vs. nationwide, 1988–2007 55 2 Oregon U.S.

1 Cases/100,000

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Malaria cases by continent of acquisition: Oregon, 2007

South America 7%

Asia 21%

Africa 72%

56

2007 Oregon Communicable Disease Summary Measles

Measles is an acute, highly communicable viral illness known for its red, blotchy that starts on the face and then becomes generalized. The rash is preceded by a febrile prodrome that includes cough, coryza and , and sometimes photophobia and Koplik spots. Diagnosis is confirmed by the presence of serum IgM antibodies (in a patient who has not recently been immunized).

During 1989–1991, a major resurgence of measles occurred in the United States. More than 55,000 cases and greater than 120 measles-related deaths were reported. The resurgence was characterized by an increasing proportion of cases among unvaccinated preschool-aged children. A focus on increasing vaccination among preschool children by following the 1989 recommendation for two doses of MMR vaccine resulted in a dramatic reduction in illness.

Measles is no longer endemic in the United States. However, cases are occasionally imported; in 2007, a case was diagnosed in a person who traveled to Japan. A close contact of this case resulted in an indigenous case. Though measles is highly infectious, the risk of exposure to measles in Oregon remains low. Sustaining high levels of vaccination is important to limit the spread of measles from imported cases and to prevent it from becoming re-established as 57 an endemic disease in the United States.

2007 Oregon Communicable Disease Summary Measles by year: Oregon, 1988–2007

250

200

150 Cases 100

50

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Incidence of measles: Oregon vs. nationwide, 1988–2007

58 15 Oregon U.S.

10 Cases/100,000 5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Measles by country of importation: 1998–2007

Hong Kong Kenya 11% 11%

Saudi Arabia 22%

Japan 45%

Europe 11%

59

2007 Oregon Communicable Disease Summary Meningococcal disease

Reported cases of invasive meningococcal infections, including sepsis and meningitis, have declined from the hyperendemic levels seen in 1993–1997 to those observed prior to the advent of the enzyme-type 5 (ET5) strain of serogroup B. Respiratory secretions and droplets continue to be shared among Oregonians and predispose secondary cases.

In 2007, 32 cases of meningococcal disease were reported, at least a 20-year low. Though Oregon’s trend is one of decline, we do continue to have higher rates than the nation. In 2007, the highest majority (53%) of illness in Oregon was once again caused by serogroup B organisms. December through March shows an increase in meningococcal activity, with the highest rates of disease occurring among infants. Higher rates are also seen in those aged 10–19 years and in persons more than 70 years of age. Though a new conjugate vaccine (Menectra) for adolescents and young adults was licensed in 2006, this vaccine does not protect against serogroup B disease.

Meningococcal disease by year: Oregon, 1988–2007

160

140 60

120

100

80 Cases

60

40

20

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Meningococcal disease by onset month: Oregon, 2007 9 2007 Median 2002—2006 8

7

6

5 Cases 4

3

2

1

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

Incidence of meningococcal disease by age and sex: Oregon, 2007 61 10 Male Female

8

6

4 Cases/100,000

2

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

2007 Oregon Communicable Disease Summary Incidence of meningococcal disease: Oregon vs. nationwide, 1988–2007 5 Oregon U.S.

4

3

2 Cases/100,000

1

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

Meningococcal disease by serogroup: Oregon, 2007 62 Y 19%

W135 6% B Non-typeable 53% 3%

C 19%

2007 Oregon Communicable Disease Summary Incidence of meningococcal disease by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–0.5

Harney Malheur Coos Douglas 0.6–1.2

1.3–2.0

2.1–3.3 Lake Josephine Jackson Klamath

Curry 3.4–5.2

63

2007 Oregon Communicable Disease Summary Mumps

Mumps is an acute viral illness characterized by fever and swelling of the salivary glands, typically the parotids. Transmission is generally airborne through respiratory droplets or through direct contact with nasal secretions.

Reporting of this vaccine-preventable viral infection was discontinued in Oregon in 1981. Once an almost universal childhood infection, mumps incidence decreased in the United States with routine childhood vaccination. Mumps reporting was re-established in Oregon July 1, 2006, prompted by outbreaks of illness among both vaccinated and unvaccinated persons. One case of mumps was reported in 2007.

Because as many as 20% of mumps infections are asymptomatic, and nearly 50% are associated with non-specific or primarily respiratory symptoms (with or without parotitis), mumps infections are significantly underreported.

In response to the 2006 nationwide mumps outbreak, the Advisory Committee on Immunization Practices (ACIP) updated its recommendations for prevention and control of mumps, with vaccination remaining the cornerstone of prevention. 64

2007 Oregon Communicable Disease Summary Pertussis

Pertussis is a highly contagious acute bacterial infection of the respiratory tract attributable to Bordetella pertussis. It is transmitted from person to person through contact with respiratory secretions (droplet transmission). Illness presents as an irritating cough that gradually becomes paroxysmal, and more than 50% of cases develop the characteristic inspiratory “whoop.” In 2004, reported cases reached the highest level since 1959. Although down considerably from levels seen in 2004 and 2005, case counts were up from 2006 and pertussis transmission continued in 2007. Because pertussis often goes undiagnosed in adolescents and adults, it is likely that the actual number of cases greatly exceeds the number reported.

In Oregon, most hospitalizations and all deaths from pertussis are reported in infants less than 6 months of age, but substantial morbidity occurs in other age groups. Adolescents, included in the 10 to 19-year-old group, have high documented rates, and Oregon has seen a number of large and disruptive outbreaks among middle school and high school students. Pertussis vaccine, available for adolescents and adults as Tdap, should provide some immunity to the disease for all of us older kids. Health care workers in particular are encouraged to get a dose. 65 Pertussis by year: Oregon, 1988–2007 700

600

500

400 Cases 300

200

100

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Pertussis by onset month: Oregon, 2007

70 2007 Median 2002–2006

60

50

40 Cases 30

20

10

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

Incidence of pertussis by age and sex: Oregon, 2007 66 25 Male Female

20

15

10 Cases/100,000

5

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

2007 Oregon Communicable Disease Summary Incidence of pertussis: Oregon vs. nationwide, 1988–2007 25 Oregon U.S.

20

15

Cases/100,000 10

5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

Incidence of pertussis by county of residence: Oregon, 1998–2007 67

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–2.0

Harney Malheur Coos Douglas 2.1–3.6

3.7–5.4

5.5–15.1 Josephine Jackson Klamath Lake

Curry 15.2–38.6

2007 Oregon Communicable Disease Summary Rabies

Rabies is an acute infection of the central nervous system caused by a neurotropic rhabdovirus of the genus Lyssavirus. All mammals, including humans, are susceptible to rabies. In humans, rabies causes a rapidly progressive and fatal encephalomyelitis. The incubation period in humans is usually two to 12 weeks, but there have been documented incubation periods as long as seven years. Bites from infected animals constitute the primary route of transmission. Transplanted organs including corneas from patients with undiagnosed rabies have also caused infection in recipients.

The Pacific Northwest is considered to be free of terrestrial rabies. In Oregon, the main reservoirs of rabies are bats and animals such as foxes and cats that may come in contact with rabid bats. An average of 10% of the bats tested in Oregon are positive for rabies. This is a targeted sample of bats that have bitten humans and animals. Bat contact and bat bites should be carefully evaluated in a timely manner. Twelve bats tested positive in 2007, down from a 20-year high of 23 rabid bats in 2006.

Oregon State Public Health Laboratories will test most human exposures and Oregon State University, Veterinary Diagnostic laboratory should test for 68 animal-to-animal exposures. All potential human exposures should result in a call to a local public health department office.

Persons not previously immunized for rabies who are exposed to a rabid animal should obtain human rabies immune globulin (HRIG) infiltrated at the site of the bite and five doses of rabies vaccine, one each on days 0, 3, 7, 14 and 28.

Though bats are the reservoir in Oregon, canine rabies still accounts for the majority of human rabies cases worldwide. Travelers to rabies-enzootic countries should be warned to seek immediate medical care if they are bitten by any mammal.

Additional information and an algorithm to follow for assessment of rabies risk are provided here. For a larger copy of this algorithm visit: www.oregon.gov/ DHS/ph/acd/diseases/rabies/Visio-RabiesAlgorithm2_08.pdf

2007 Oregon Communicable Disease Summary Rabies tests: Oregon, 1990–2007 (Number of positive/total tested)

Year Bat Cat Dog Fox Other animals 1990 1/29 0/61 0/34 0/1 0/14 1991 4/40 1/85 1/54 1/4 0/19 1992 2/29 0/98 0/54 0/4 0/54 1993 2/43 1/96 0/34 4/10 0/59 1994 10/47 0/88 0/58 3/7 0/78 1995 3/47 0/98 0/61 5/5 0/159 1996 3/48 0/51 0/33 0/5 0/58 1997 14/116 1/83 0/52 0/6 0/45 1998 6/95 0/95 0/56 0/3 0/49 1999 11/115 1/95 0/45 0/1 1/47 (Cow) 2000 8/73 0/79 0/56 1/4 0/4 2001 4/59 0/67 0/46 0/1 0/41 2002 12/134 0/102 0/27 2/4 0/29 2003 6/61 0/75 0/36 1/5 0/39 2004 7/88 0/105 0/42 0/2 0/27 2005 8/83 0/100 0/48 0/1 0/23 2006 23/126 0/72 0/26 2/4 0/41 2007 12/153 0/80 0/33 0/1 0/26 69 136/1386 4/1530 1/798 19/68 1/812 Totals 9.8% 0.26% 0.12% 28% 0.1%

2007 Oregon Communicable Disease Summary Incidence of animal rabies cases by county: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–0.1

Harney Malheur Coos Douglas 0.2–0.3

0.4–0.6

0.7–1.0 Josephine Jackson Klamath Lake

Curry 1.1–1.4

70

2007 Oregon Communicable Disease Summary ls, I:\Diseases\Rabies\2008 bviousalternative noo eor otherwise exposepersons, pets orlivestock bit Health Laboratory 503-229-5882 blic OregonDepartment of Human Services Acute andCommunicable Disease Prevention Office ofOffice Disease Prevention Epidemiologyand de, example, for a young child'swaking up andcrying, witha weekdays, nights andweekends, 971-673-1111 arantine" means confininga dog, cat or ferretfor 10days to observe signs for of Qu hey are bindingnot onclinicians. Clinicians should advisedbe that, aside from concern areavailable the followingday. Abbreviations OSPHL: OregonState Pu PEParethe purviewof the clinician attendingthe patient;although theserecommendations regardingthe need rabiesfor PEP represent the best judgmentofstate public-health officia Laboratory(541-737-3261) privateat expense. 4. Evidenceofownership might include, e.g., presence ofcollar or previous appearances of the animal ina neighborhood. 5. " StatePublic Health Veterinarian or designee (OR333-019-0022). 8. Batch testing rabies for is generally doneat OSPHL on Mondays Wednesdays.and Results arequite rare. Examples ofprovocation wouldinclude being hit a by car; being handled, fed. orcaged; being cornered in a garage;having a jogger pastrun youryard; or crowding animal'sspace, etc. 7. purposes For determiningof need for rabiesPEP, wolf-hybrids are consideredwild animals and not dogs. Wolf-doghybridsthat depending on thenature ofthe wound andthe animal involved. Localhealth department personnel are advised tocall Acute and CommunicableDisease Prevention 971-673-1111at withspecific questions regardingapplication of theseguidelines. 2. Such evidencemightinclu publichealth authority for thejurisdiction inwhich the patient resides.Decisions about rabies bat foundbat room.thein 3. "No Test"means that the animal will not testedbe at OSPHL, at expense. state In such cases,the animal may be testedat theOregon State University Veterinary Diagnostics shouldbe considered for euthanasia rabiesand examination. Whetheran animal is dog a or awolf-dog hybrid must be determinedby a licensed veterinarian, subject reviewto the by motivationfor theanimal bite.A goodto historyis In essential. practice,unprovoked bites about rabies,prophylaxis against tetanusbacterialor infection might warranted,be illnessafter biting human a being. The nature of the confinementis determined by the local publichealth authority. If the animal develops neurological illness during the periodof quarantine, it should euthanizedbe and headits shipped OSPHLto for testing within one workingday. 6. "Unprovoked"implies that,inthecontext ofthesituation, there was Notes 1. Oregon law mandatesreporting of any bite ofa human being by anyother mammal (OregonAdministrative Rule333-018-0015[5] [c]); such reportsshould madebe to the local t PEP:Epi: post-exposureprophylaxis againstrabies Epidemiologists theat Oregon Department of Human Services; Test 28% 9.8% No No PEP PEP 0.26% 0.12% PEP (1) Yes

No No Yes 4 4 1,530 (6) testing? Available for Definitely unprovoked No Rabies Oregon testing, 1991-2007 Dog 1 798 Fox 19 68 Cat Animal Positive Bat Tested Positive % 136 1,386 Epi NoPEP

Discuss with 71 (8) No day thatthere Is it certain orscratch? wasnobite Discuss Epiwith batch No TestOSPHL Yes PEP TestOSPHL nextworking (5) Yes No Yes Yes Yes NoPEP Quarantine No (6) Definitely unprovoked testing? No Availablefor Yes (3) testing? Stat Alive? timeof NoPEP Availablefor Notest (3) No Batlive at encounter? TestOSPHL NoPEP Notest (5) Yes (3) PEP Yes Yes NoPEP No test testing? Yes Quarantine Definitely provoked? Yes Availablefor No No Yes No Algorithm for Prevention of Rabies After Animal Encounters inof AfterAnimal Prevention for Rabies OregonAlgorithm No (3) (2) No No (6) NoPEP Definitely No No test unprovoked Wasthere suggesting evidence testing? physical contact? testing? (4) Available for Yes Availablefor owned? todate? thatcat is Evidence Vaccination definitely up Fox biteFox Otheranimal bite Catbite Dogor ferret bite Bat encounter

2007 Oregon Communicable Disease Summary Salmonellosis

Salmonellosis is a bacterial illness characterized by acute abdominal pain, diarrhea, and often fever that begins 12 hours to five days after infection. In cases of enterocolitis, fecal excretion usually persists for several days or weeks beyond the acute phase of illness. Antibiotics generally have no effect on the illness and, in fact, may increase the duration of organism excretion.

A wide range of domestic and wild animals are carriers of Salmonella, including poultry, swine, cattle, , iguanas, tortoises, turtles, young poultry, dogs and cats. The majority of human infections are thought to result from the ingestion of fecally contaminated food or water. Raw or undercooked produce and products of animal origin such as eggs, milk, meat and poultry have been implicated as common sources of animal and human salmonellosis. Though uncommon, person-to-person spread can occur in humans via patients, convalescent carriers and, especially, mild and unrecognized cases. The incidence of infection is highest in infants and young children.

Of approximately 2,500 known serotypes, only about 200 are detected in the United States in any given year. In Oregon, S. Typhimurium and S. Enteritidis are the two most commonly reported. 72 In 2007, 10 outbreaks of salmonellosis were investigated in Oregon. Of those, seven were confirmed to be foodborne, one was related to animal contact, and in two the source of the Salmonella could not be determined.

2007 Oregon Communicable Disease Summary Salmonellosis by year: Oregon, 1988–2007

600

500

400

300 Cases

200

100

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Salmonellosis by onset month: Oregon, 2007

60 2007 Median 2002—2006 73

50

40

30 Cases

20

10

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of salmonellosis by age and sex: Oregon, 2007

40 Male Female

35

30

25

20

Cases/100,000 15

10

5

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of salmonellosis: Oregon vs. nationwide, 1988–2007 74 25 Oregon U.S.

20

15

Cases/100,000 10

5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Incidence of salmonellosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–2.8

Harney Malheur Coos Douglas 2.9–8.2

8.3–10.9

Lake 11.0–13.4 Josephine Jackson Klamath Curry 13.5–24.7

Selected* Salmonella by serotype, Oregon, 1998–2007 75

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Enteritidis 42 33 45 34 43 78 64 86 74 54 Heidelberg 14 20 10 26 27 12 42 51 19 26 Montevideo 10 17 20 13 17 16 15 15 13 12 Muenchen 5 73 6 8 10 5 7 8 8 9 Newport 10 12 9 16 31 38 14 17 16 17 Oranienburg 11 7 7 10 12 13 6 8 5 8 Paratyphi B var. Java 7 7 6 9 8 7 17 20 7 11 Saintpaul 17 6 12 4 18 36 16 7 10 3 Typhimurium 112 101 72 86 67 83 86 84 90 52 *Selected because at least one case was reported in 2007 and it is a more common serotype.

2007 Oregon Communicable Disease Summary Shigellosis

Shigellosis is an acute bacterial infection characterized by (sometimes bloody) diarrhea, vomiting, abdominal cramps and, often, fever. Humans are the only known reservoir. Shigellosis is transmitted from person to person, and just a few organisms can cause illness. It is important to track the incidence of this disease to see trends and to detect outbreaks. The rate is higher among children 1–4 years of age. The incidence of shigellosis usually increases in late summer and fall. A large community-wide outbreak in 1991 resulted in hundreds of cases in multiple Portland metropolitan area daycare centers from April onward. At the tail end of that summer, in August, additional cases were associated with a duel pathogen outbreak (E. coli and Shigella) at Blue Lake Park in Fairview.

Outbreaks in daycare centers are common, mainly due to the poor hygienic practices of small children. Hand washing is the most important means of prevention. Treatment reduces duration of illness, but the organism has become resistant to many antibiotics used for empiric therapy. Testing for antibiotic susceptibility is important for treatment.

The number of cases in 2007 decreased to 87, the same number of cases 76 reported in 2004, which was a 20-year low. Thirteen of these cases were presumptive cases with household transmission of illness. A small cluster of seven cases appeared to be person-to-person transmission within an elementary school. No other outbreaks were reported.

2007 Oregon Communicable Disease Summary Shigellosis by year: Oregon, 1988–2007

800

700

600

500

400 Cases

300

200

100

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Shigellosis by onset month: Oregon, 2007

20 2007 Median 2002—2006 77 18

16

14

12

Cases 10

8

6

4

2

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of shigellosis by age and sex: Oregon, 2007 8 Male Female 7

6

5

4

Cases/100,000 3

2

1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of shigellosis: Oregon vs. nationwide, 1988–2007 78 25 Oregon U.S.

20

15

Cases/100,000 10

5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

2007 Oregon Communicable Disease Summary Shigellosis by species: Oregon, 2007

S. boydii 1%

S. flexneri 36%

S. sonnei 63%

Incidence of shigellosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. 79 River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0–0.33

Harney Malheur Coos Douglas 0.34–2.4

2.5–6.1

Lake 6.2–13 Josephine Jackson Klamath

Curry 14–37

2007 Oregon Communicable Disease Summary Early syphilis

Syphilis is a sexually transmitted disease of protean manifestation caused by the spirochete Treponema pallidum. Early syphilis cases represent an aggregate of primary, secondary and early latent cases of less than one year’s duration. The 26 early syphilis cases reported in 2007 reflect a 22-case decrease (54%) compared to the 48 cases reported during 2006. Twenty-one percent of the early syphilis cases reported during 2007 were among men who have sex with men. The infection may be transmitted among sex partners during the primary and second stages.

Syphilis is transmitted via vaginal, rectal or oral sexual contact. Syphilis can be prevented by abstaining from sex or only having sex with one uninfected sex partner. Those who are sexually active outside of a mutually monogamous relationship can lower their risks of infection by using a condom when engaging in sexual activity.

It is important to identify and treat persons with early syphilis to prevent late complications, such as brain and heart damage, and to prevent congenial infections. Moreover, persons with primary or secondary syphilis more easily acquire and transmit HIV. An effective way to limit the spread of syphilis is to 80 evaluate and treat recent sex partners of persons with early syphilis.

Early syphilis by year: Oregon, 1988–2007 600

500

400

300 Cases

200

100

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year 2007 Oregon Communicable Disease Summary Incidence of early syphilis by age and sex: Oregon, 1998–2007 5 Male Female

4

3

2 Cases/100,000

1

0

0-4 5-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-85+ Age

Incidence of primary and secondary syphilis: Oregon vs. nationwide, 1988–2007* 81 30 Oregon U.S.

25

20

15 Cases/100,000 10

5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

*For national surveillance, only primary and secondary syphilis cases are tracked and reported 2007 Oregon Communicable Disease Summary Incidence of early syphilis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000

0.0

Harney Malheur Coos Douglas 0.1–0.3

0.4–0.8

Lake 0.9–1.6 Josephine Jackson Klamath

Curry 1.7–3.8

82

2007 Oregon Communicable Disease Summary Tuberculosis

Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis. The most common site for active TB disease is the lung; however, TB can occur in any organ in the body. TB is spread when persons with active pulmonary or laryngeal TB cough the bacteria into the air, and other persons inhale the bacteria into their lungs.

TB is preventable, treatable and curable. TB can be prevented by diagnosing and treating persons with active TB disease. It can also be prevented by identifying and treating persons with latent TB infection who, if untreated, are likely to develop active TB disease. Reporting of TB ensures that cases are treated and that contacts are identified and offered preventive antibiotics. The standard initial treatment for active TB in Oregon includes four drugs: INH, rifampin, pyrazinamide, and ethambutol pending susceptibility testing. Multidrug-resistant tuberculosis (MDR TB) is resistant to two or more of the standard TB drugs and requires treatment with second-line drugs.

The incidence rate of TB has been declining over the past decade. In 2007, a total of 94 cases of active TB disease were verified in Oregon, for a rate of 2.5 cases per 100,000 residents. Though an increase from the rate of 2.2 per 100,000 residents in 2006, Oregon’s TB rate continues to meet the Healthy People 2010 83 goal of less than 3.5/100,000.

2007 Oregon Communicable Disease Summary Tuberculosis by year: Oregon, 1988–2007

200

180

160

140

120

100 Cases 80

60

40

20

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

Incidence of tuberculosis by age and sex: Oregon, 2007

5 Male Female 84

4

3

2 Cases/100,000

1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

2007 Oregon Communicable Disease Summary Incidence of tuberculosis: Oregon vs. nationwide,1988–2007 15 Oregon U.S.

10 Cases/100,000 5

0

19881989199019911992199319941995199619971998199920002001200220032004200520062007 Year

Tuberculosis cases by country of birth, foreign-born vs. U.S.-born: 85 Oregon, 1998–2007

90 Foreign-born U.S.-born 80 70 60 50

Cases 40 30 20 10 0

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Incidence of tuberculosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–0.5

Harney Malheur Coos Douglas 0.6–1.3

1.4–2.2

Lake 2.3–4.5 Josephine Jackson Klamath

Curry 4.6–6.4

86

2007 Oregon Communicable Disease Summary Tularemia

Tularemia, also known as rabbit or deer-fly fever, has recently gained notoriety as a possible “category A” agent of bioterrorism. Tularemia is caused by Francisella tularensis, a hardy organism found in rodents, rabbits and squirrels; in ticks, flies and mosquitoes; and in contaminated soil, water and animal carcasses. Biovar type A, the most common type in North America, is highly virulent; as few as 10–50 organisms can cause disease.

General symptoms of tularemia include fever, malaise, myalgias, headache, chills, rigors and sore throat. Tularemia has six clinical forms, depending on portal of entry. Ulceroglandular tularemia is the most common form of the disease, accounting for 75% to 85% of naturally occurring cases. Other clinical forms include: pneumonic (pulmonary symptoms); typhoidal (gastral- intestinal symptoms and sepsis); glandular (regional adenopathy without skin lesion); oculoglandular (painful, purulent conjunctivitis with adenopathy); and oropharyngeal (pharyngitis with adenopathy).

Tularemia occurs throughout the United States. Persons become infected primarily through handling contaminated animals; the bite of infective deer flies, mosquitoes or ticks; direct contact with or ingestion of contaminated food, water or soil; or inhalation of infective aerosols. From 1998 to 2007, 20 cases of 87 tularemia were reported in Oregon. Cases occurred in residents of 12 counties and were evenly spread across age groups. In 2007, there were three cases.

2007 Oregon Communicable Disease Summary Tularemia by year: Oregon, 1988–2006

6

5

4

3 Cases

2

1

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

88

2007 Oregon Communicable Disease Summary Vibriosis

Vibriosis is caused by infection with Vibrio bacteria. Vibrio is a species of bacteria that cause watery diarrhea, abdominal cramps and fever. Vibrio are commonly found in coastal marine waters and, therefore, in filter-feeding shellfish such as oysters (which, for this reason, should be eaten only when fully cooked).

V. vulnificus, a species that occurs primarily in the Gulf of Mexico, can cause sepsis in immunocompromised persons, and infections caused by toxigenic V. cholerae are notifiable as cholera. V. parahaemolyticus occurs naturally in Pacific coastal waters, especially during warmer months, and is by far the most common species diagnosed in Oregon.

In 2007, eight laboratory-confirmed vibriosis cases were reported in Oregon. One infection was V. vulnificus, and the rest of the cases were attributed to V. parahaemolyticus. The majority (88%) of cases were male, aged 20–51 years.

Non-cholera Vibrio infections were not nationally reportable until 2007 and not reportable in Oregon prior to 1998. Case reporting is essential to the identification of contaminated shellfish beds and removal of these shellfish from the raw seafood market. 89 Vibrio parahaemolyticus infections: Oregon, 1988–2007

20

15

10 Cases Not reportable until 1998

5

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

2007 Oregon Communicable Disease Summary Vibrio parahaemolyticus by onset month: Oregon, 2007

6 2007 Median 2002—2006

5

4

3 Cases

2

1

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month 90

2007 Oregon Communicable Disease Summary West Nile virus

West Nile virus (WNv) first appeared in the United States in 1999, and has moved westward across the country. In Oregon, the first case was reported in 2004. West Nile virus is a mosquito-borne virus that affects both animals and humans. Birds are the reservoir; humans and other animals are considered “dead-end” hosts.

Of those infected, one in five will have mild symptoms such as fever, headache and muscle aches; fewer people, about one in 150, will have more severe symptoms that may include neck stiffness, stupor, disorientation, tremors, convulsions, muscle weakness, paralysis and coma. The risk of getting West Nile virus in Oregon has been very low. Though most cases were in those aged 20–50 years, those over 50 years of age have the highest risk of developing serious illness. The incidence in summer months is higher.

In 2006, a record 74 human cases were reported. In 2007, a total of 27 humans, 52 birds, 16 horses, 11 sentinel chickens, two pet dogs and one squirrel were diagnosed with WNv infection. Of the 27 human cases, the median age was 52 years; seven (26%) were neuroinvasive, and 15 (55%) were reported in males. Twenty-six of them acquired WNv in Oregon and one person contracted WNv in another state. Of the 26 Oregon residents, one of the cases developed WNv 91 as a result of an organ transplant. The organ recipient developed neuroinvasive disease. Further investigation revealed that, although the organ donor was positive for WNv, the person died of non-WNv related causes.

2007 Oregon Communicable Disease Summary West Nile virus by year: Oregon, 1988–2007 80

70

60

50

40 Cases

30

20 No Oregon cases until 2003 10

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Year

West Nile virus by month of onset: Oregon, 2007

50 2006 2007 92 45

40

35

30

25 Cases

20

15

10

5

0 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Month

2007 Oregon Communicable Disease Summary Incidence of West Nile virus by age and sex: Oregon, 2007 3 Male Female

2 Cases/100,000 1

0

0–4 5–9 80+ 10–19 20–29 30–39 40–49 50–59 60–69 70–79 Age

Incidence of West Nile virus by county of residence: Oregon, 2005–2007 93

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 0.0–0.2

Harney Malheur Coos Douglas 0.3–1.0

1.1–8.0

Lake 8.1–26.1 Josephine Jackson Klamath

Curry 26.2–72.5

2007 Oregon Communicable Disease Summary Yersiniosis

Yersiniosis is a bacterial infection characterized by (sometimes bloody) diarrhea, vomiting and abdominal pain. The main reservoir forYersinia is the . Transmission occurs via the fecal-oral route through contaminated food and water, or through contact with infected people or animals. Preventive measures include cooking food thoroughly, avoiding cross-contamination with raw food of animal origin, and washing hands after handling food.

The incidence of yersiniosis in Oregon has been fairly stable over the years. In 2003, the number of cases dropped to six, the lowest reported incidence since 1995. The 18 cases reported in 2007 are slightly above the mean of 14 cases reported each year since the new millennium. Yersiniosis occurs throughout the year with no seasonality. The most common species (75%) isY. enterocolitica.

Yersiniosis by year: Oregon, 1988–2007

30

25

20

15 Cases

10

5

0

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007

94 Year

2007 Oregon Communicable Disease Summary Incidence of yersiniosis by age and sex: Oregon, 1998–2007

2 Male Female

1 Cases/100,000

0

0–4 5–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–85+ Age

Incidence of yersiniosis by county of residence: Oregon, 1998–2007

Clatsop

Columbia Umatilla Hood Wallowa Wash. Mult. River Morrow Tillamook Union Clackamas Sherman Yamhill Gilliam Wasco Polk Marion Wheeler Baker Jefferson Lincoln Linn Grant Benton

Crook Lane Deschutes Rate per 100,000 95 0.0–0.1

Harney Malheur Coos Douglas 0.2

0.3–0.7

0.8–1.2 Lake Josephine Jackson Klamath

Curry 1.3–5.3

2007 Oregon Communicable Disease Summary Disease outbreaks

Oregon state and local health departments investigated a record number (231) of communicable disease outbreaks in 2007. The majority (120) of these were person-to-person transmissions of causing in the elder inhabitants of Oregon’s assisted and long-term care facilities, or younger populations in restricted environments such as the state hospital or prison. However, there were a number of outbreaks of other bacterial and viral pathogens. Sharing of respiratory secretions caused clusters of influenza (3), pertussis (4), meningococcal disease (2) and adenovirus (2). Thirty-nine outbreaks of foodborne transmission were identified. Foods contaminated with a garden variety of Salmonella made folks ill at a variety of venues including restaurants, markets and fairs. Every outbreak reinforces the age-old public health mantras — “wash your hands” and “cover your cough.”

120 Norwalk-like viruses 10 Salmonella 5 sapovirus 5 varicella 4 pertussis 3 3 E. coli O157:H7 Disease outbreaks 3 influenza by etiology: 2007 2 Staphylococcus aureus 2 meningococcal disease 2 adenovirus 1 Shigella 1 hepatitis C 96 1 Cryptosporidium 1 measles 1

2007 Oregon Communicable Disease Summary Public health reporting for clinicians

By law1, Oregon clinicians must report diagnoses (confirmed or suspected) of the specified infections, diseases and conditions. Both lab-confirmed cases and clinically suspect cases are reportable. The parallel system of lab reporting does not obviate the clinician’s obligation to report. Some conditions (e.g., uncommon illnesses of public health significance, animal bites, HUS, PID, poisoning, disease outbreaks) are rarely if ever identified by labs. In short, we depend upon clinicians to report. Reports should be made to the patient’s local health department2 and should include at least the patient’s name, home address, phone number, date of birth, sex, diagnosis, and the date of symptom onset. Most reports should be made within one working day of the diagnosis, but there are several important exceptions.

Disease reporting enables appropriate public health follow-up for your patients, helps identify outbreaks, provides a better understanding of morbidity patterns, and may even save lives. Remember that HIPAA does not prohibit you from reporting protected health information to the public health authorities for the purpose of preventing or controlling disease, including public health surveillance and investigations; see 45 CFR 164.512(b)(1)(i).

REPORT IMMEDIATELY Rubella 97 Anthrax Vibrio infection Diphtheria REPORT WITHIN ONE WORKING DAY Marine intoxication3 Animal bites Plague Any arthropod-borne infection6 SARS-coronavirus Brucellosis Any outbreak of disease4 Campylobacteriosis Any uncommon illness of potential Chancroid public health significance5 Chlamydia infection7 Cruetzfeld-Jakob disease (CJD) and REPORT WITHIN 24 HOURS other prion diseases Haemophilus influenzae Cryptosporidiosis Measles (rubeola) Cyclospora infection Meningococcal disease Escherichia coli (Shiga-toxigenic)8 Pesticide poisoning Giardiasis Polio Gonorrhea Rabies Hantavirus infection

2007 Oregon Communicable Disease Summary Hepatitis A FOOTNOTES 1. ORS 433.004; OAR 333-018-0000 to 333- Hepatitis B 018-0015. Hepatitis C 2. Refer to www.oregon.gov/DHS/ph/acd/ reporting/disrpt.shtml for a list of local Hepatitis D (delta) health departments and more details about what to report. HIV infection and AIDS 3. Paralytic , scombroid, domoic Hemolytic-uremic syndrome (HUS) acid intoxication, ciguatera, etc. 4. Outbreaks are ≥ 2 cases from separate Legionellosis households associated with a suspected common source. Leptospirosis 5. We can’t list every exotic disease in the world. Listeriosis Ask yourself “Might there be public health implications from a case of possible Ebola, Lyme disease smallpox, meliodosis, or whatever?” If the answer is “yes” – or even “maybe” – then pick Lymphogranuloma venereum (LGV) up the phone. There are no penalties Malaria for overreporting. 6. Including any viral, bacterial, and parasitic Mumps infections typically spread by ticks, mosquitos, Pelvic inflammatory disease fleas and their ilk (e.g., relapsing fever, typhus, babesiosis, dengue, , Colorado tick (acute, non-gonococcal) fever, ehrlichiosis, yellow fever, Chagas disease, leishmaniasis, SLE, WEE, EEE, CCHF, etc.) Pertussis 7. STDs, trachoma, TWAR, psittacosis – all of ’em – Psittacosis even if they’re named Chlamydophila. 8. E. coli O157:H7 is the exemplar of this group. Q fever 9. Fax all childhood diabetes cases to 971-673- 0994. (Forms available at www.healthoregon. Rocky Mountain spotted fever org/diabetes.) Salmonellosis (including typhoid) Shigellosis 98 Syphilis infection/ Tetanus Trichinosis Tuberculosis Tularemia West Nile virus Yersiniosis

REPORT WITHIN ONE WEEK Diabetes in person ≤ 18 years old9

2007 Oregon Communicable Disease Summary Public health reporting for laboratories

By law1, Oregon labs must report all test results “indicative of and specific for” the following diseases, infections, and conditions. These results include microbiological culture, isolation or identification; assays for specific antibodies; and identification of specific antigens, or nucleic acid sequences.

In general, reports must be made to the patient’s local health department2 within one working day of the initial test report. Laboratories identifying possible agents of bioterrorism should contact their local health department and refer the isolates to the Oregon State Public Health Laboratory immediately, day or night. Reports must include the patient’s name and county of residence, the specimen collection date, lab test and result, and contact information for the ordering clinician and the lab. If available, the patient’s address, date of birth and sex are much appreciated.

The lab that reports to the clinician is responsible for reporting, regardless of who actually does the test. Out-of-state residents may document reports in a log sent directly to the state office; .

BACTERIA Haemophilus influenzae3,5 99 Bacillus anthracis Haemophilus ducreyi Bordetella pertussis Legionella Borrelia Leptospira Brucella monocytogenes3 Campylobacter Mycobacterium tuberculosis3 Chlamydia psittaci Chlamydia trachomatis Neisseria gonorrhoeae Clostridium botulinum Neisseria meningitidis3,5 Clostridium tetani Rickettsia Corynebacterium diphtheriae Salmonella3 Coxiella burnetii Shigella3 Ehrlichia Treponema pallidum Escherichia coli -- Shiga-toxigenic3,4 Vibrio3 Francisella tularensis Yersinia3

2007 Oregon Communicable Disease Summary PARASITES OTHER IMPORTANT REPORTABLES Cryptosporidium Any “uncommon illness of potential Cyclospora public health significance”2 Giardia Any outbreak of disease2 Plasmodium Any other typically arthropod Taenia solium6 vector-borne infection2 All blood lead testing results All CD4 cell counts and HIV viral loads VIRUSES Creutzfeldt-Jakob disease (CJD) and Hantavirus other prion illnesses Hepatitis A7 7 NOTES Hepatitis B 1. ORS 433.004; OAR 333-018-0000 to 333- Hepatitis C 018-0015. 2. Refer to www.oregon.gov/DHS/ph/acd/ Hepatitis D (Delta) reporting/disrpt.shtml for a list of local health departments, reporting FAQs, and more details HIV infection and AIDS about what to report. When in doubt, report. Measles (Rubeola) 3. Isolates must be forwarded to the Oregon State Public Health Laboratory (phone, 503-693-4100). Mumps 4. Including all confirmed or suspected Polio E. coli O157. 5. Report only isolates from normally sterile sites Rabies (e.g., neither sputum nor throat cultures). 6. Report cysticercosis and all undifferentiated Rubella Taenia sp., (e.g., eggs in stool O & P). SARS-coronavirus 7. IgM positive HAV and HBV specimens must be forwarded to the Oregon State Public West Nile Health Laboratory. Yellow Fever

100

2007 Oregon Communicable Disease Summary 8 7 0 0 3 2 16 87 18 14 79 22 61 32 33 94 66 24 463 336 124 729 1235 9867 2007 0 4 3 2 15 13 16 22 19 92 27 86 41 47 81 55 48 121 425 428 112 652 1460 9576 2006 6 1 4 2 2 13 11 17 15 19 97 56 47 53 57 127 417 417 149 622 647 103 1562 9019 2005 7 8 0 1 2 0 19 87 14 11 68 17 61 65 49 58 443 416 625 112 656 106 1302 8690 2004 5 6 5 1 3 0 3 10 17 16 60 62 42 74 981 211 406 427 101 438 119 597 106 7500 2003 9 9 9 0 2 2 0 14 16 13 44 61 57 47 929 106 431 337 204 193 126 575 111 7200 2002 4 6 0 8 1 3 14 12 12 91 15 66 65 38 22 115 535 288 166 598 109 123 1145 7504 2001 6 1 7 0 4 2 0 41 10 18 71 30 31 159 673 300 134 105 123 568 164 119 1039 7110 2000 2 3 0 7 1 9 22 17 18 68 29 61 75 49 37 906 102 792 422 122 599 248 123 6163 1999 1 5 0 9 1 4 3 16 18 17 89 85 41 32 880 187 892 344 107 186 698 430 156 5857 1998 7 0 3 5 0 48 26 11 15 92 12 49 36 773 195 879 366 131 736 109 387 161 5254 1997 1 4 1 70 23 15 18 23 57 14 32 886 151 899 381 102 164 702 114 883 188 5442 1996 7 0 7 3 1 1 67 23 13 94 57 27 854 174 897 345 186 626 118 156 5468 2929 1995 101 4 1 5 4 2 16 11 16 67 25 100 977 166 937 337 111 232 656 136 165 5494 1366 1994 0 1 3 2 4 11 14 10 15 185 158 346 253 105 282 712 101 581 153 1192 1000 5539 1993 6 9 2 0 2 1 3 24 16 45 72 218 280 478 154 278 850 506 146 1768 1178 5885 1992 3 5 0 6 2 28 13 20 66 81 93 277 721 378 114 305 966 446 144 2172 1301 7327 1991 5 0 5 3 67 21 22 56 75 87 212 261 180 357 122 415 951 809 148 2549 1359 7387 1990 3 4 0 6 4 82 83 20 11 28 22 70 424 123 325 569 998 151 3025 1062 6734 2322 1989 5 6 5 0 0 7 2 17 16 51 53 134 515 108 410 582 945 161 3221 1152 7135 1438 1988 Measles H. influenzae infection Early syphilis* Malaria * Case counts by onset year except for where noted with indicating date of report Blank cells = not reportable Data as of 7/15/08 Gonorrhea* Shigellosis Listeriosis Yersiniosis Giardiasis Salmonellosis Legionellosis Vibrio Vibrio parahaemolyticus E. coli O157 Infection Rubella Acute hepatitis C Typhoid fever Typhoid Chlamydiosis* Pertussis Acute hepatitis B Tularemia Campylobacteriosis Meningococcal disease Hepatitis A Tuberculosis* Selected cases of notifiable diseases by year*, Oregon 1988-2007 CD Data as of 7/15/200 8 **Number persons living HIV/AIDS Selected cases of notifiable diseases Total Yamhill Wheeler Washington Wasco Wallowa Union Umatilla Tillamook Sherman Polk Multnomah Morrow Marion Malheur Linn Lincoln Lane Lake Klamath Josephine Jefferson Jackson Hood River Harney Grant Gilliam Douglas Deschutes Curry Crook Coos Columbia Clatsop Clackamas Benton Baker 2,825 4920 411 330 296 139 257 43 15 38 11 27 19 54 37 22 57 12 16 65 77 11 37 25 25 35 0 2 9 1 6 2 1 4 0 7 4 AIDS/HIV** 100 729 138 14 20 11 12 54 12 10 22 56 63 52 86 Campylo 4 9 8 7 4 2 9 7 2 1 4 0 0 8 0 1 1 3 2 1 2 4 bacteriosis 1014 1035 9867 2928 405 189 204 135 284 113 171 194 117 208 848 530 734 75 60 36 85 99 98 46 18 96 36 22 13 37 11 0 6 2 7 9 2 Chlamydiosis 163 23 11 27 26 40 7 1 0 1 1 2 1 1 0 1 0 0 0 0 6 0 5 4 0 0 2 0 0 0 0 1 0 2 0 0 1 Cryptosporidiosis 10 10 12 13 79 E. coli O157 4 2 1 2 3 0 0 1 1 3 0 4 0 0 1 0 4 1 1 0 0 1 0 0 0 0 0 2 0 3 0 0 infection 141 463 by county of residence: Oregon, 2007 31 10 10 11 48 28 57 19 29 8 3 9 8 5 5 9 0 0 2 5 0 1 8 2 4 0 0 0 2 5 2 1 0 0 0 Giardiasis 1235 124 112 647 10 11 33 16 10 14 53 52 79 6 1 7 8 6 7 7 0 8 0 2 5 3 1 0 0 0 7 3 3 0 0 0 0 Gonorrhea 10 12 66 4 1 2 1 2 2 5 4 0 3 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 1 0 0 0 0 0 9 H. influenzae 14 33 3 0 2 0 0 0 0 0 2 1 1 2 1 1 1 0 0 0 0 0 2 0 0 0 0 0 1 1 1 0 0 0 0 0 0 Hepatitis A 18 61 Hepatitis B 0 0 5 0 0 3 2 2 5 0 5 0 2 0 0 0 0 0 0 0 0 0 0 0 0 2 9 2 6 0 0 0 0 0 0 (acute) 170 462 95 10 39 10 33 32 Hepatitis B 9 6 2 5 1 5 3 5 7 2 3 0 3 0 3 0 1 1 1 0 0 1 8 2 2 0 3 0 0 (chronic)

22 Hepatitis C 0 0 1 0 0 1 0 0 0 0 0 2 0 0 0 0 2 0 0 1 1 0 0 0 0 0 5 1 2 0 0 0 1 0 5 0 (acute) 0 0 0 2 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 9 1 HUS 14 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3 0 0 0 0 0 7 102 0 Legionellosis 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 2 8 0 Listeriosis 27 1 0 0 0 1 1 0 0 1 1 1 1 0 3 0 0 0 0 1 0 3 0 0 0 0 0 0 6 2 0 0 0 0 0 5 0 Lyme disease 11 16 0 0 0 0 0 0 0 0 2 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 Malaria

32 Meningococcal 0 2 0 0 4 0 1 0 2 2 0 5 0 0 2 0 0 0 1 0 1 0 0 0 0 0 3 2 2 0 0 0 0 0 5 0 disease 124 18 14 13 22 21 0 0 1 0 1 0 0 2 5 1 5 0 4 0 0 0 0 0 0 8 0 0 0 0 5 4 0 0 0 0 0 Pertussis 12 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 1 0 0 0 0 0 1 2 0 Rabies, animal 336 16 44 12 24 11 24 27 43 63 4 5 2 9 5 6 6 3 6 5 0 3 0 0 1 3 0 0 0 0 4 3 1 1 3 2 0 Salmonellosis 13 34 87 0 0 2 0 2 0 0 3 0 1 1 1 0 0 0 7 0 0 4 5 1 0 0 0 0 1 3 7 0 2 0 0 0 0 Shigellosis 24 13 0 0 1 0 1 1 0 0 2 0 1 1 2 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Early Syphillis 94 17 10 12 28 3 0 2 1 2 1 0 0 1 1 3 0 2 0 0 0 0 8 0 0 0 0 0 1 0 1 0 0 0 1 0 0 Tuberculosis

Vibrio 0 7 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 parahaemolyticus 27 11 0 2 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 5 0 0 0 2 1 0 West Nile 18 0 0 0 0 0 2 0 0 2 0 0 1 0 0 0 0 0 0 0 0 5 1 0 0 0 0 0 4 0 0 0 0 0 0 3 0 Yersiniosis

2007 Oregon Communicable Disease Summary

Public Health Division Office of Disease Prevention and Epidemiology Acute and Communicable Disease Prevention Oregon Department 800 N.E. Oregon Street, Suite 772 Portland OR 97232 of Human Services Phone 971-673-1111 E-mail [email protected] Web site http://oregon.gov/DHS/ph/acd